Diagnosis of Celiac Disease in Adults Based on Serology Test Results, Without Small-Bowel Biopsy

Clinical Gastroenterology and Hepatology

Volumn 11, Issue 5, 2013, Pages 511-516

  Wakim Fleming, Jamile' ^a,b   Pagadala, Mangesh R ^a   Lemyre, Martin S ^b   Lopez, Rocio ^a   Kumaravel, Arthi ^a   Carey, William D ^a   Zein, Nizar N ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b METROHEALTH MEDICAL CENTER   (United States)

Author keywords

Antibodies; Autoimmune; Celiac Disease; Enteropathy

Indexed keywords

ENDOMYSIUM ANTIBODY; GLIADIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ADULT; ANTIBODY TITER; ARTICLE; CELIAC DISEASE; DIAGNOSTIC TEST ACCURACY STUDY; DILUTION; DISEASE ASSOCIATION; FALSE POSITIVE RESULT; FEMALE; GLUTEN FREE DIET; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMMUNOGLOBULIN BLOOD LEVEL; INTESTINE BIOPSY; MAJOR CLINICAL STUDY; MALE; MUCOSAL DISEASE; PATHOLOGIST; PREDICTIVE VALUE; RETROSPECTIVE STUDY; SEROLOGY;

ADULT; AGED; AUTOANTIBODIES; CELIAC DISEASE; FEMALE; GLIADIN; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEROLOGIC TESTS; TRANSGLUTAMINASES;

EID: 84876714808     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2012.12.015     Document Type: Article

References (41)

1. NIH Consensus Development Conference on Celiac Disease. NIH consensus and state-of-the-science statements. 2004;21:1-23.
2. Fasano A., Berti I., Gerarduzzi T., et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 2003, 163:286-292.
3. Dubé C., Rostom A., Sy R., et al. The prevalence of celiac disease in average-risk and at-risk western European populations: a systematic review. Gastroenterology 2005, 128:S57-S67.
4. Green P.H.R., Stavropoulos S.N., Panagi S.G., et al. Characteristics of adult celiac disease in the USA: results of a national survey. Am J Gastroenterol 2001, 96:126-131.
5. Norström F., Lindholm L., Sandström O., et al. Delay to celiac disease diagnosis and its implications for health-related quality of life. BMC Gastroenterol 2011, 11:118.
6. Murray J.A. Celiac disease in patients with an affected member, type 1 diabetes, iron-deficiency, or osteoporosis?. Gastroenterology 2005, 128:S52-S56.
7. Gasbarrini G., Miele L., Malandrino N., et al. Celiac disease in the 21st century: issues of under- and over-diagnosis. Int J Immunopathol Pharmacol 2009, 22:1-7.
8. Godfrey J.D., Brantner T.L., Brinjikji W., et al. Morbidity and mortality among older individuals with undiagnosed celiac disease. Gastroenterology 2010, 139:763-769.
9. Hin H., Bird G., Fisher P., et al. Coeliac disease in primary care: case finding study. BMJ 1999, 318:164-167.
10. Rubio-Tapia A., Kyle R.A., Kaplan E.L., et al. Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology 2009, 137:88-93.
11. Collin P., Kaukinen K., Vogelsang H., et al. Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis of coeliac disease: a biopsy-proven European multicentre study. Eur J Gastroenterol Hepatol 2005, 17:85-91.
12. Dickey W. Symposium on "Coeliac disease: basics and controversies." Coeliac disease in the twenty-first century. Proc Nutr Soc 2009, 68:234-241. Joint BAPEN and British Society of Gastroenterology.
13. Parakkal D., Du H., Semer R., et al. Do gastroenterologists adhere to diagnostic and treatment guidelines for celiac disease?. J Clin Gastroenterol 2012, 46:e12-e20.
14. Catassi C., Fasano A. Celiac disease diagnosis: simple rules are better than complicated algorithms. Am J Med 2010, 123:691-693.
15. Kurien M., Evans K.E., Hopper A.D., et al. Duodenal bulb biopsies for diagnosing adult celiac disease: is there an optimal biopsy site?. Gastrointest Endosc 2012, 75:1190-1196.
16. Rashid M., MacDonald A. Importance of duodenal bulb biopsies in children for diagnosis of celiac disease in clinical practice. BMC Gastroenterol 2009, 9:78.
17. Salmi T.T., Collin P., Reunala T., et al. Diagnostic methods beyond conventional histology in coeliac disease diagnosis. Dig Liver Dis 2010, 42:28-32.
18. Katz K.D., Rashtak S., Lahr B.D., et al. Screening for celiac disease in a North American population: sequential serology and gastrointestinal symptoms. Am J Gastroenterol 2011, 106:1333-1339.
19. Fasano A. Should we screen for coeliac disease? Yes. BMJ Clin Res Ed 2009, 339:b3592.
20. Green P.H., Neugut A.I., Naiyer A.J., et al. Economic benefits of increased diagnosis of celiac disease in a national managed care population in the United States. J Insur Med 2008, 40:218-228.
21. Mariné M., Fernández-Bañares F., Alsina M., et al. Impact of mass screening for gluten-sensitive enteropathy in working population. World J Gastroenterol 2009, 15:1331-1338.
22. AGA Institute medical position statement on the diagnosis and management of celiac disease. Gastroenterology 2006, 131:1977-1980. AGA Institute.
23. Rostom A., Murray J.A., Kagnoff M.F. American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology 2006, 131:1981-2002.
24. Marsh M.N. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ("celiac sprue"). Gastroenterology 1992, 102:330-354.
25. Leffler D.A., Schuppan D. Update on serologic testing in celiac disease. Am J Gastroenterol 2010, 105:2520-2524.
26. Ravelli A., Villanacci V., Monfredini C., et al. How patchy is patchy villous atrophy?. Distribution pattern of histological lesions in the duodenum of children with celiac disease. Am J Gastroenterol 2010, 105:2103-2110.
27. Kakar S., Nehra V., Murray J.A., et al. Significance of intraepithelial lymphocytosis in small bowel biopsy samples with normal mucosal architecture. Am J Gastroenterol 2003, 98:2027-2033.
28. Hopper A.D., Cross S.S., Sanders D.S. Patchy villous atrophy in adult patients with suspected gluten-sensitive enteropathy: is a multiple duodenal biopsy strategy appropriate?. Endoscopy 2008, 40:219-224.
29. Hill P.G., Holmes G.K. Coeliac disease: a biopsy is not always necessary for diagnosis. Aliment Pharmacol Ther 2008, 27:572-577.
30. Mubarak A., Wolters V.M., Gerritsen S.A., et al. A biopsy is not always necessary to diagnose celiac disease. J Pediatr Gastroenterol Nutr 2011, 52:554-557.
31. DeLong E.R., DeLong D.M., Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988, 44:837-845.
32. Ravelli A., Villanacci V. Tricks of the trade: how to avoid histological pitfalls in celiac disease. Pathol Res Pract 2012, 208:197-202.
33. Hill I.D. What are the sensitivity and specificity of serologic tests for celiac disease?. Do sensitivity and specificity vary in different populations?. Gastroenterology 2005, 128:S25-S32.
34. Naiyer A.J., Hernandez L., Ciaccio E.J., et al. Comparison of commercially available serologic kits for the detection of celiac disease. J Clin Gastroenterol 2009, 43:225-232.
35. Husby S., Koletzko S., Korponay-Szabó I.R., et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 2012, 54:136-160.
36. Hopper A.D., Hadjivassiliou M., Hurlstone D.P., et al. What is the role of serologic testing in celiac disease?. A prospective, biopsy-confirmed study with economic analysis. Clin Gastroenterol Hepatol 2008, 6:314-320.
37. Taavela J., Kurppa K., Collin P., et al. Degree of damage to the small bowel and serum antibody titers correlate with clinical presentation of patients with celiac disease. Clin Gastroenterol Hepatol 2013, 11:166-171.
38. Abrams J.A., Diamond B., Rotterdam H., et al. Seronegative celiac disease: increased prevalence with lesser degrees of villous atrophy. Dig Dis Sci 2004, 49:546-550.
39. Vermeersch P., Geboes K., Mariën G., et al. Defining thresholds of antibody levels improves diagnosis of celiac disease. Clin Gastroenterol Hepatol 2012 Oct 25, Epub ahead of print.
40. Bizzaro N. The predictive significance of autoantibodies in organ-specific autoimmune diseases. Clin Rev Allergy Immunol 2008, 34:326-331.
41. Nahin R.L., Barnes P.M., Stussman B.J., et al. Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States, 2007. Natl Health Stat Rep 2009, 18:1-14.